Literature DB >> 1594240

cdc2-like kinase is associated with the retinoblastoma protein.

M Kitagawa1, S Saitoh, H Ogino, T Okabe, H Matsumoto, A Okuyama, K Tamai, Y Ohba, H Yasuda, S Nishimura.   

Abstract

The growth-suppressive activity of the retinoblastoma (RB) protein is suggested to be regulated by phosphorylation. In studies on the kinase that phosphorylates the RB proteins, we have previously found that RB proteins can be phosphorylated by purified cdc2 kinase. In this study, we noted that RB proteins immunoprecipitated from human cell lysates are weakly phosphorylated in the absence of purified cdc2 kinase. Immunoblot analysis showed the presence of p34cdc2 in the immunoprecipitates with anti-RB monoclonal antibody. In addition, the coprecipitated kinase was found to have the same substrate specificity as cdc2 kinase. The associated kinase activity was particularly high in cells arrested in G1/S and S phase by aphidicolin. Furthermore, RB proteins were shown to be phosphorylated in nuclear extracts by some endogenous cdc2-like kinase(s). These results suggest that cdc2-like kinase is the main kinase for phosphorylation of RB proteins in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594240

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer.

Authors:  E Wakasugi; T Kobayashi; Y Tamaki; Y Nakano; Y Ito; I Miyashiro; Y Komoike; M Miyazaki; T Takeda; T Monden; M Monden
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

Review 2.  Adenovirus-E1A proteins transform cells by sequestering regulatory proteins.

Authors:  D S Peeper; A Zantema
Journal:  Mol Biol Rep       Date:  1993-04       Impact factor: 2.316

3.  The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Authors:  M Kitagawa; H Higashi; H K Jung; I Suzuki-Takahashi; M Ikeda; K Tamai; J Kato; K Segawa; E Yoshida; S Nishimura; Y Taya
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

4.  Overexpression of CDK2 is a prognostic indicator of oral cancer progression.

Authors:  M Mihara; S Shintani; Y Nakahara; A Kiyota; Y Ueyama; T Matsumura; D T Wong
Journal:  Jpn J Cancer Res       Date:  2001-03

5.  Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer.

Authors:  H Yamamoto; T Monden; K Ikeda; H Izawa; K Fukuda; M Fukunaga; N Tomita; T Shimano; H Shiozaki; M Monden
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.